Friday, July 10, 2026

pharma · Immunotherapy · Opioid Analgesic Adverse Reaction

Second Affiliated Hospital

Second Affiliated Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Immunotherapy, Opioid Analgesic Adverse Reaction, Liver Cancer, Ulcerative Colitis (UC). NovaPharmaNews lin

CN HQ
103 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
103
Programs
4
Drugs
11
Patents
0
Clinical program

Cadonilimab

Phase 2 · small molecule · Immunotherapy

Cadonilimab for Immunotherapy is a Phase 2 program (small_molecule) at Second Affiliated Hospital of Soochow University with 1 ClinicalTrials.gov record(s).

Internal code SAHZunyiMU

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Second Affiliated Hospital of Soochow University
Phase
Phase 2
Modality
small_molecule
Indication
Immunotherapy
Status
active
Trials
1